New Research Shows Promise and Limitations of Physicians Working with GPT-4 for Decision Making

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied how well doctors used GPT-4 - an artificial intelligence (AI) large language model system - for diagnosing patients.

The study was conducted with 50 U.S.-licensed physicians in family medicine, internal medicine and emergency medicine. The research team found that the availability of GPT-4 to physicians as a diagnostic aid did not significantly improve clinical reasoning compared to conventional resources. Other key findings include:

  • GPT-4 alone demonstrated significantly better scores in diagnostic performance, surpassing the performance of clinicians using conventional diagnostic online resources and clinicians assisted by GPT-4.
  • There was no significant enhancement in diagnostic performance with the addition of GPT-4 when assessing clinicians using GPT-4 against clinicians using conventional diagnostic resources.

"The field of AI is expanding rapidly and impacting our lives inside and outside of medicine. It is important that we study these tools and understand how we best use them to improve the care we provide as well as the experience of providing it," said Andrew Olson, MD, a professor at the U of M Medical School and hospitalist with M Health Fairview. "This study suggests that there are opportunities for further improvement in physician-AI collaboration in clinical practice."

These results underline the complexity of integrating AI into clinical practice. While GPT-4 alone showed promising results, the integration of GPT-4 as a diagnostic aid alongside clinicians did not significantly outperform the use of conventional diagnostic resources. This suggests a nuanced potential for AI in healthcare, emphasizing the importance of further exploration into how AI can best support clinical practice. Further, more studies are needed to understand how clinicians should be trained to use these tools.

The four collaborating institutions have launched a bi-coastal AI evaluation network - known as ARiSE - to further evaluate GenAI outputs in healthcare.

Funding for this research was provided by the Gordon and Betty Moore Foundation.

Goh E, Gallo R, Hom J, Strong E, Weng Y, Kerman H, Cool JA, Kanjee Z, Parsons AS, Ahuja N, Horvitz E, Yang D, Milstein A, Olson APJ, Rodman A, Chen JH.
Large Language Model Influence on Diagnostic Reasoning: A Randomized Clinical Trial.
JAMA Netw Open. 2024 Oct 1;7(10):e2440969. doi: 10.1001/jamanetworkopen.2024.40969

Most Popular Now

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...